-
EP3092256
European procedure
Extract from the Register of European Patents
EP About this file: EP3092256
| EP3092256 - COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.03.2023 Database last updated on 15.11.2024 | |
| Former | The patent has been granted Status updated on 15.04.2022 | ||
| Former | Grant of patent is intended Status updated on 03.01.2022 | ||
| Former | Examination is in progress Status updated on 06.04.2020 | Most recent event Tooltip | 15.11.2024 | Change - lapse in a contracting state Updated state(s): BG | published on 18.12.2024 [2024/51] | Applicant(s) | For all designated states Birdie Biopharmaceuticals Inc. Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay Grand Cayman / KY | [2022/19] |
| Former [2016/49] | For all designated states Birdie Biopharmaceuticals Inc. Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay Grand Cayman / KY | ||
| Former [2016/46] | For all designated states Shanghai Birdie Biotech Inc. 1-4-13 1 Xiushui Road Chaoyang District Beijing 100600 / CN | Inventor(s) | 01 /
LI, Lixin 1-4-13 1 Xiushui Road Chaoyang Beijing 100600 / CN | [2016/46] | Representative(s) | Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB | [N/P] |
| Former [2022/19] | Mitchell, Simon James Murgitroyd & Company London Euston House 24 Eversholt Street London NW1 1AD / GB | ||
| Former [2016/46] | Green, Mark Charles Urquhart-Dykes & Lord LLP The Podium 1 Eversholt Street London NW1 2DN / GB | Application number, filing date | 15734849.1 | 08.01.2015 | [2016/46] | WO2015CN70379 | Priority number, date | CN20141011324 | 10.01.2014 Original published format: CN201410011324 | CN20141011262 | 10.01.2014 Original published format: CN201410011262 | CN20141011362 | 10.01.2014 Original published format: CN201410011362 | [2016/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015103989 | Date: | 16.07.2015 | Language: | EN | [2015/28] | Type: | A1 Application with search report | No.: | EP3092256 | Date: | 16.11.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.07.2015 takes the place of the publication of the European patent application. | [2016/46] | Type: | B1 Patent specification | No.: | EP3092256 | Date: | 18.05.2022 | Language: | EN | [2022/20] | Search report(s) | International search report - published on: | CN | 16.07.2015 | (Supplementary) European search report - dispatched on: | EP | 13.04.2018 | Classification | IPC: | C07K16/32, A61K31/4745, A61K31/522, A61P35/00, A61P35/02 | [2018/04] | CPC: |
C07K16/32 (EP,US);
A61K45/06 (US);
A61K47/6803 (EP,US);
A61K47/6849 (EP,US);
A61K47/6851 (EP,US);
A61K47/6855 (EP,US);
A61K47/6857 (EP,US);
A61K47/6863 (EP,US);
A61K47/6871 (EP,US);
A61K47/6889 (EP,US);
A61P1/04 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P13/08 (EP,US);
A61P13/10 (EP,US);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P35/00 (EP,US);
A61P35/02 (EP);
A61P37/02 (EP);
A61P43/00 (EP,US);
|
| Former IPC [2016/46] | C07K16/32, A61K31/4745, A61K31/522, A61K47/48, A61P35/00, A61P35/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/46] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | VERBINDUNGEN UND ZUSAMMENSETZUNGEN FÜR DIE IMMUNTHERAPIE | [2016/46] | English: | COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY | [2016/46] | French: | COMPOSÉS ET COMPOSITIONS POUR L'IMMUNOTHÉRAPIE | [2016/46] | Entry into regional phase | 08.07.2016 | National basic fee paid | 08.07.2016 | Search fee paid | 08.07.2016 | Designation fee(s) paid | 08.07.2016 | Examination fee paid | Examination procedure | 08.07.2016 | Examination requested [2016/46] | 02.11.2018 | Amendment by applicant (claims and/or description) | 09.04.2020 | Despatch of a communication from the examining division (Time limit: M04) | 10.08.2020 | Reply to a communication from the examining division | 15.09.2021 | Despatch of a communication from the examining division (Time limit: M04) | 11.10.2021 | Reply to a communication from the examining division | 04.01.2022 | Communication of intention to grant the patent | 08.04.2022 | Fee for grant paid | 08.04.2022 | Fee for publishing/printing paid | 08.04.2022 | Receipt of the translation of the claim(s) | Divisional application(s) | EP22167502.8 / EP4056594 | Opposition(s) | 21.02.2023 | No opposition filed within time limit [2023/17] | Fees paid | Renewal fee | 30.05.2017 | Renewal fee patent year 03 | 29.01.2018 | Renewal fee patent year 04 | 28.01.2019 | Renewal fee patent year 05 | 27.01.2020 | Renewal fee patent year 06 | 27.01.2021 | Renewal fee patent year 07 | 27.01.2022 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.01.2017 | 03 M06 Fee paid on 30.05.2017 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 18.05.2022 | BG | 18.05.2022 | CZ | 18.05.2022 | EE | 18.05.2022 | FI | 18.05.2022 | HR | 18.05.2022 | LT | 18.05.2022 | LV | 18.05.2022 | MC | 18.05.2022 | PL | 18.05.2022 | RO | 18.05.2022 | RS | 18.05.2022 | SI | 18.05.2022 | SK | 18.05.2022 | SM | 18.05.2022 | NO | 18.08.2022 | GR | 19.08.2022 | IS | 18.09.2022 | PT | 19.09.2022 | LU | 08.01.2023 | [2024/51] |
| Former [2024/29] | AL | 18.05.2022 | |
| CZ | 18.05.2022 | ||
| EE | 18.05.2022 | ||
| FI | 18.05.2022 | ||
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| MC | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RO | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| SI | 18.05.2022 | ||
| SK | 18.05.2022 | ||
| SM | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| IS | 18.09.2022 | ||
| PT | 19.09.2022 | ||
| LU | 08.01.2023 | ||
| Former [2023/43] | AL | 18.05.2022 | |
| CZ | 18.05.2022 | ||
| EE | 18.05.2022 | ||
| FI | 18.05.2022 | ||
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RO | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| SI | 18.05.2022 | ||
| SK | 18.05.2022 | ||
| SM | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| IS | 18.09.2022 | ||
| PT | 19.09.2022 | ||
| LU | 08.01.2023 | ||
| Former [2023/25] | AL | 18.05.2022 | |
| CZ | 18.05.2022 | ||
| EE | 18.05.2022 | ||
| FI | 18.05.2022 | ||
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RO | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| SI | 18.05.2022 | ||
| SK | 18.05.2022 | ||
| SM | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| IS | 18.09.2022 | ||
| PT | 19.09.2022 | ||
| Former [2023/17] | AL | 18.05.2022 | |
| CZ | 18.05.2022 | ||
| EE | 18.05.2022 | ||
| FI | 18.05.2022 | ||
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RO | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| SK | 18.05.2022 | ||
| SM | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| IS | 18.09.2022 | ||
| PT | 19.09.2022 | ||
| Former [2023/09] | CZ | 18.05.2022 | |
| EE | 18.05.2022 | ||
| FI | 18.05.2022 | ||
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RO | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| SK | 18.05.2022 | ||
| SM | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| IS | 18.09.2022 | ||
| PT | 19.09.2022 | ||
| Former [2022/51] | FI | 18.05.2022 | |
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| IS | 18.09.2022 | ||
| PT | 19.09.2022 | ||
| Former [2022/50] | FI | 18.05.2022 | |
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| PL | 18.05.2022 | ||
| RS | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| PT | 19.09.2022 | ||
| Former [2022/49] | FI | 18.05.2022 | |
| HR | 18.05.2022 | ||
| LT | 18.05.2022 | ||
| LV | 18.05.2022 | ||
| BG | 18.08.2022 | ||
| NO | 18.08.2022 | ||
| GR | 19.08.2022 | ||
| PT | 19.09.2022 | ||
| Former [2022/47] | FI | 18.05.2022 | |
| LT | 18.05.2022 | ||
| NO | 18.08.2022 | ||
| PT | 19.09.2022 | Cited in | International search | [X]WO2008079924 (3M INNOVATIVE PROPERTIES CO [US], et al) | by applicant | US4689338 | US4880935 | EP0404097 | US5122368 | WO9301161 | US5226575 | US5229275 | WO9316185 | US5270163 | US5352784 | US5389640 | US5482936 | US5567610 | US5567588 | US5571894 | US5587458 | US5595877 | US5622929 | US5660985 | US5696249 | WO9808856 | US5763177 | US5789163 | US5817785 | US5824805 | US5843732 | US5843653 | US5853984 | US5869046 | US5874218 | US5958691 | US5977089 | US6001577 | US6005087 | US6031086 | US6110929 | US6127533 | US6184364 | US6194425 | US6214345 | US6225460 | US6242246 | US6248516 | US6331539 | US6344318 | US6376190 | US2002064780 | US6399754 | US6403779 | WO0246192 | WO0246193 | WO0246194 | US6451810 | US6458543 | US6458539 | US6465189 | US6482594 | WO02100442 | US2003054360 | US2003087301 | US2003175950 | US2004014779 | WO2004010957 | US2004043923 | US6716583 | US2004072234 | US2004092470 | US2004162309 | US2004192626 | US2005020525 | US2005032733 | US2005069910 | WO2006117217 | US7157452 | US7301027 | US2012141509 | US2012149061 | US8246968 | US2012237977 | US2012288512 | US2013150558 | US8513390 | US8518404 | US2014256922 |